Last month, Project Achieve staff and collaborators from Columbia Collaborative HIV/AIDS Clinical Trials Unit gathered for a National HIV Testing Day event in Union Square Park. There, they distributed educational materials and spoke with community members about HIV prevention, vaccine research, and intervention trials.
New York Blood Center’s Post
More Relevant Posts
-
"SKIP TO CONTENT Find Testing, PrEP, & HIV Care Services EN ESPAÑOL Find Services TEST PREP TREAT STDs FAQs News Mpox Stories Videos, Banners, Graphics Campaigns National HIV Community Partnership Join Us En Español It’s fast and easy. Rapid testing provided by local partners with results in minutes. No appointment needed. Enter City or ZIP CodeFIND FREE TESTING FREE rapid syphilis and hepatitis C testing available at many locations. Find out about the latest in prevention and treatment, including PrEP, the medication to prevent HIV. Together We Are Greater Than HIV Advances in prevention and treatment are bringing us closer to ending HIV. It begins with a test. If you are not able to make it to a participating Walgreens on June 27, free HIV testing is offered year-round by local health departments and clinics, including self-testing options in many areas. PrEP prevents HIV. When taken as prescribed, PrEP reduces the chances of getting HIV by 99%. Available as a daily pill or long-acting injectable. Find out if PrEP is right for you. Undetectable is untransmittable. With ongoing treatment, HIV can be reduced to very low levels. So low, it can’t be detected or transmitted sexually. Stay healthy, protect others. Make STD testing routine. Like HIV, many other common STDs often show no symptoms. Left untreated, STDs can cause serious health issues. All STDs are treatable, many are curable. Pssst…pass it on! Downloadable digital graphics to share on social media and embed on websites. GET STARTED A public-private partnership with health departments and community organizations to expand HIV testing and information. More than 82,000 free HIV tests have been provided through the Greater Than HIV / Walgreens National HIV Community Partnership, including 15,000 self-tests during COVID-19, and even more have been reached with HIV information and resources. LEARN MORE Make Your Community Greater Than HIV Download and order materials to support your online and community outreach. GET STARTED Stay Connected Sign up for the latest Greater Than HIV news and updates! EmailSIGN UP © 2024 Greater Than HIV About Contact Us Privacy Policy Disclaimer " https://lnkd.in/ehZk2D4f
Let's Get Tested!
https://www.greaterthan.org
To view or add a comment, sign in
-
Report from library knowledge share. UK Health Security Agency (UKHSA); 2023. [The HIV Action Plan monitoring and evaluation framework reports measure progress towards England’s long-term commitment to end HIV transmission by 2030. These annual reports specifically focus on the interim ambitions of England’s HIV Action Plan 2022 to 2025 to reduce HIV diagnosis first made in England by (80%), AIDS-defining conditions diagnosed within 90 days of HIV diagnosis (by 50%) between 2019 and 2025. This report summarises progress from 2019 to 2022.]
HIV Action Plan monitoring and evaluation framework
gov.uk
To view or add a comment, sign in
-
The first steps towards ensuring a world without AIDS include:1. *Increase awareness and education*: Educate people about HIV/AIDS, its transmission, prevention, and treatment.2. *Improve access to HIV testing*: Make HIV testing widely available, accessible, and affordable.3. *Provide antiretroviral therapy (ART)*: Ensure universal access to ART for all people living with HIV.4. *Prevent mother-to-child transmission*: Implement programs to prevent mother-to-child transmission of HIV.5. *Implement harm reduction strategies*: Provide access to needle exchange programs, safe injection sites, and opioid substitution therapy.6. *Promote condom use and safe sex practices*: Encourage safe sex practices and provide access to condoms.7. *Address stigma and discrimination*: Work to reduce stigma and discrimination against people living with HIV/AIDS.8. *Support research and development*: Continuously fund research for new treatments, vaccines, and prevention methods.9. *Strengthen healthcare systems*: Ensure healthcare systems are equipped to provide quality HIV services.10. *Mobilize communities and resources*: Engage communities, governments, and organizations to prioritize HIV/AIDS efforts.These initial steps lay the groundwork for a comprehensive response to the HIV/AIDS pandemic, ultimately moving us closer to a world without AIDS.
To view or add a comment, sign in
-
The FDA has approved the use of Dovato in treating HIV-1 infection in adolescents aged 12 and above weighing at least 25 kg. This approval is a significant milestone, as it is the first oral, two-drug, single-tablet regimen available for adolescents living with HIV. Dovato is a combination of dolutegravir and lamivudine, which work together to inhibit the virus at two different stages of its replication cycle. Based on data from the DANCE study, the majority of adolescents who took Dovato achieved and maintained viral suppression for 48 weeks. The safety and efficacy of Dovato in adolescents were comparable to those observed in adults, with no clinically significant adverse effects noted despite higher exposures to the components of Dovato. This expanded indication for Dovato provides adolescents with a more convenient and effective treatment option that requires fewer medications. It underscores ViiV Healthcare’s commitment to developing and delivering innovative therapies for people living with HIV, including young people. According to Lynn Baxter, Head of North America at ViiV Healthcare, this approval is an important step in addressing the treatment needs of young people with HIV. As a leader in HIV care, ViiV Healthcare remains dedicated to improving and expanding treatment options for children and adolescents, particularly in communities where access to care may be limited. #HIVtreatment #Dovato #ViiVHealthcare #adolescenthealth #innovativetherapies #FDAapproval
ViiV’s Dolutegravir/Lamivudine FDA Approved for HIV-Positive Adolescents
https://www.clinicaltrialvanguard.com
To view or add a comment, sign in
-
To improve care for people living with #HIV, Ukraine aims to deliver a guaranteed package of services at the primary health care level. But are PHC facilities in Ukraine prepared to offer person-centered, integrated HIV services? And if not, what do they need to get there? 🚗 We traveled the country to find out. The PATH-led, USAID-funded Re-envisioning Excellence and Accessibility in Clinic-based HIV Services (REACH 95) Activity is working with the government of Ukraine to increase equitable access to high-quality HIV care. To kick off the project, our team visited 62 health care facilities in 16 regions to conduct in-person and virtual baseline assessments on the current landscape of HIV service delivery, as well as gaps and needs. REACH 95’s goal is in its name: ensuring that 95% of people living with HIV know their HIV status, 95% of people who know their status are receiving HIV treatment, and 95% of people on treatment are virally suppressed by 2030. In Ukraine, reaching these targets is possible. Read more: https://lnkd.in/ezHmgbEf #AIDS2024 #PutPeopleFirst Kateryna (Katya) Gamazina Svitlana Leontyeva Volodymyr Kochanov Jessica Farley Lisa Mueller Scott
Integrating HIV services into primary health care in Ukraine
path.org
To view or add a comment, sign in
-
Chief Commercial Officer I CCO I UBC I Driving Revenue Growth Through Creative Strategy & Effective Tactical Execution | Building High Performing Teams & Winning Cultures | Leading Healthcare Tech Pharmaceutical Services
Exciting news in the fight against HIV! HIV Prevention. The U.S. has officially commenced clinical trials for a new HIV prevention injection that could be administered just twice a year. This innovative approach has the potential to revolutionize HIV prevention, making it more accessible and convenient for those at risk. Current HIV prevention methods, like daily oral PrEP (pre-exposure prophylaxis), have proven effective but require strict adherence to daily medication, which can be challenging for many individuals. The new twice-yearly injection aims to address this issue by providing a long-acting solution that reduces the burden of daily medication and improves adherence rates. So how does it work? The injection works by delivering a sustained release of antiretroviral drugs that help prevent the virus from establishing an infection. This method not only simplifies the prevention process but also offers a discreet and less intrusive option compared to daily pills. Check out this piece for more info: https://lnkd.in/edGP79Pg #HIV #Trials #ClinicalTrials #Pharma #Healthcare #Innovation
To view or add a comment, sign in
-
Advancements in HIV/AIDS Treatment and Prevention Significant progress has been made in the fight against HIV/AIDS, with advancements in treatment and prevention offering hope for ending the epidemic. Antiretroviral therapy \(ART\) has transformed HIV from a fatal disease into a manageable chronic condition, improving the quality of life and life expectancy for millions of people living with HIV. Prevention strategies, including pre-exposure prophylaxis \(PrEP\) and comprehensive sexual education, have been effective in reducing new HIV infections. Increasing access to these preventive measures, parti... https://lnkd.in/d9tT8X_B #HIVAIDS >>>Read full article by clicking the link below...
Advancements in HIV/AIDS Treatment and Prevention
https://www.odrimedia.co.ke
To view or add a comment, sign in
-
Case studies from EpiC Nepal and Eswatini are highlighted in the World Health Organization’s launch of the new HIV testing guidelines to underscore the potential for HIV self-testing and PrEP integration and illustrate the different ways programmes successfully implement WHO recommendations. Read it here: https://bit.ly/3WVEYX2
Countries take up new WHO recommendations on self-testing for PrEP and PEP
who.int
To view or add a comment, sign in
-
Important read on the importance of "Test and Treat" Campaigns for HIV, Hep B and Hep C.
Combined “Test and Treat” Campaigns for HIV, Hepatitis B and Hepatitis C: A Systematic Review to Provide Evidence to Support WHO Treatment Guidelines
academic.oup.com
To view or add a comment, sign in
-
Understanding Your Options PrEP and HIV prevention Did you know PrEP (Pre-Exposure Prophylaxis) is a powerful tool for preventing HIV transmission? Taking PrEP involves regular check-ups every three months for HIV screening and monitoring. It's designed for individuals at higher risk of HIV exposure, providing them with an effective preventive measure. PrEP represents a significant advancement in the fight against HIV/AIDS, offering hope and protection to many. By taking a daily pill, individuals can greatly reduce their risk of acquiring HIV. It's about taking action before exposure to decrease the risk of infection. Let's spread the word about PrEP and empower more people with the knowledge to protect themselves. Together, we can make strides toward ending the HIV epidemic. https://lnkd.in/ge_GThqy
To view or add a comment, sign in
8,253 followers